Ideaya Biosciences, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
10-K: IDEAYA Biosciences Reports Promising Pipeline Progress and Financial Stability in 2024 10-K Filing
IDEAYA Biosciences highlights pipeline advancements, strategic collaborations, and a strong financial position in its 2024 annual report.
NASDAQ
IDEAYA Biosciences' 10-K filing details its capital structure, clinical pipeline, and strategic collaborations, highlighting its focus on precision medicine oncology.